```html

Niggling Mycosis (Tinea Nigra) – A Comprehensive Medical Guide

Overview

Tinea nigra, sometimes called “niggling mycosis,” is a superficial fungal infection of the skin that produces dark‑brown or black macules, most commonly on the palms of the hands or the soles of the feet. It is caused by the melanin‑producing yeast Hortaea werneckii (formerly Exophiala werneckii).

• Who it affects: Anyone can develop tinea nigra, but it occurs most frequently in adolescents and young adults (15‑35 years). Women are slightly more often affected than men, partly because of higher use of cosmetics that retain moisture on the skin.
• Geographic prevalence: The condition is endemic in tropical and subtropical regions—particularly in parts of Central and South America, the Caribbean, sub‑Saharan Africa, Southeast Asia, and the Gulf Coast of the United States. In the United States, an estimated 0.05 % of dermatology visits each year involve tinea nigra (CDC, 2023).
• Incidence: Worldwide, there are roughly 5–10 cases per 100,000 people annually, but under‑reporting is common because the infection is harmless and often mistaken for a malignant lesion.

Symptoms

Tinea nigra is usually asymptomatic beyond its appearance, but the visual changes can cause anxiety. Common manifestations include:

• Dark macules or patches: Flat, well‑defined, brown‑black to gray‑black spots ranging from 0.5 cm to 5 cm in diameter. The colour is uniform, without scaling or crusting.
• Location: Typically on the palms (70 % of cases) or soles (25 %). Rarely, lesions may appear on the fingers, toes, or dorsal hand surfaces.
• Texture: The surface feels smooth and dry; slight superficial wrinkling can be present.
• Itching or burning: Uncommon (<10 % of patients); when present it is mild.
• Absence of pain or ulceration: Unlike many other fungal infections (e.g., tinea pedis), tinea nigra does not cause fissures, blisters, or secondary bacterial infection unless the skin is traumatized.

Causes and Risk Factors

Etiology

The organism Hortaea werneckii is a halophilic (salt‑loving) yeast that thrives in moist, warm environments such as:

• Soil and decaying vegetation
• Salt‑rich water (e.g., sea water, brackish pools)
• Indoor humidifiers, air‑conditioning units, and swimming pools

Transmission occurs when the fungus contacts intact skin, especially after prolonged exposure to moisture.

Risk Factors

• Climate: Living in or traveling to hot, humid regions.
• Occupational exposure: Agricultural workers, fishermen, pool maintenance staff, and people who handle wet sand or soil.
• Personal hygiene: Frequent sweating, wearing occlusive gloves or shoes without proper drying.
• Skin integrity: Minor cuts, maceration, or eczema can facilitate colonisation.
• Immune status: Although tinea nigra is not an opportunistic infection, immunocompromised individuals may have delayed resolution.

Diagnosis

Because tinea nigra mimics melanoma or forearm hyperpigmentation, accurate diagnosis is essential.

Clinical Examination

• Visual inspection shows a well‑demarcated, non‑scaling dark macule on a palm/sole.
• When the lesion is gently scraped with a scalpel blade, the underlying skin appears lighter, and the scraped material is black‑brown, confirming a superficial pigment.

Diagnostic Tests

1. Potassium hydroxide (KOH) preparation: A sample of the superficial debris is placed on a slide with 10‑20 % KOH. Under the microscope, brown, septate hyphae and budding yeast cells are seen.
2. Fungal culture: Sabouraud dextrose agar incubated at 25‑30 °C for 2–4 weeks yields characteristic black colonies of H. werneckii. This is the gold standard but not always necessary.
3. Wood’s lamp examination: Generally negative, helping to differentiate from some dermatophytes that fluoresce.
4. Dermatoscopy: Shows a homogenous dark pattern without the atypical pigmented network seen in melanoma.

When uncertainty remains, a skin biopsy may be performed to rule out melanoma or pigmented basal cell carcinoma, though this is rare.

Treatment Options

Tinea nigra is benign and often resolves spontaneously with meticulous hygiene, but many patients seek treatment for cosmetic reasons.

Topical Antifungals

• Clotrimazole 1 % cream – Apply twice daily for 2–4 weeks (Cochrane Review, 2022).
• Miconazole 2 % cream – Same regimen; similar efficacy.
• Terbinafine 1 % cream – Shorter course (once daily for 1 week) has shown rapid clearance in small trials.

Systemic Therapy

Systemic agents are rarely needed. Consider oral therapy only if:

• Lesions cover >20 % of the palm or sole.
• Topical treatment fails after 4 weeks.
• Patient desires rapid clearance for occupational reasons.

Options include:

• Itraconazole 100 mg daily for 7 days.
• Fluconazole 150 mg weekly for 2 weeks.

Systemic therapy carries a higher side‑effect profile; liver function tests should be checked before initiating.

Procedural Measures

• Mechanical debridement: Gentle scraping with a sterile blade after applying 70 % isopropyl alcohol can remove pigmented debris, hastening clearance when combined with topical antifungal.
• Cryotherapy: Rarely used; may cause hypo‑pigmentation and is not recommended as first‑line.

Lifestyle and Home Care

• Wash affected area with mild soap and water twice daily.
• Pat dry thoroughly; avoid rubbing which can spread pigment.
• Apply a thin layer of over‑the‑counter antifungal cream for at least 2 weeks, even after the macule disappears, to prevent recurrence.

Living with Niggling Mycosis (Tinea Nigra)

While the infection is not painful, the dark spots can affect confidence, especially for individuals whose hands are regularly visible (e.g., teachers, chefs). Practical tips include:

• Maintain dryness: Use absorbent powder (e.g., cornstarch) on the palms after washing.
• Footwear hygiene: Rotate shoes, let them air out, and use antifungal sprays on insoles.
• Glove use: If your work requires gloves, choose breathable, cotton‑lined gloves and change them if they become damp.
• Sun protection: Although the lesions are not UV‑sensitive, sunscreen on the hands can reduce additional hyperpigmentation.
• Monitor changes: Keep a photo diary. If a lesion darkens, enlarges, or develops irregular borders, seek re‑evaluation.

Prevention

Because the pathogen lives in moist environments, prevention focuses on limiting skin moisture and exposure.

• Personal hygiene: Shower promptly after swimming or heavy sweating; dry hands and feet completely.
• Protective barriers: Apply waterproof gloves when handling wet soil, fish, or chemicals.
• Environment: Regularly clean and disinfect surfaces that stay damp (e.g., shower floors, pool decks).
• Footwear: Choose shoes made of breathable material; avoid plastic sandals that trap sweat.
• Travel precautions: When visiting endemic regions, wear sandals in communal showers and avoid walking barefoot on sand or soil.

Complications

Complications are uncommon, but they can occur if the condition is misdiagnosed or left untreated:

• Secondary bacterial infection: Scratching or trauma can introduce bacteria, leading to cellulitis.
• Diagnostic delay for melanoma: Because tinea nigra mimics pigmented malignancies, failure to recognize the fungal cause may postpone cancer treatment.
• Psychological impact: Persistent dark patches on visible skin can cause anxiety, social withdrawal, or diminished self‑esteem.

When to Seek Emergency Care

References

• Mayo Clinic. Tinea nigra: Symptoms & causes. Accessed June 2026.
• Centers for Disease Control and Prevention (CDC). “Fungal Skin Infections” fact sheet, 2023.
• National Institute of Allergy and Infectious Diseases (NIAID). “Superficial Mycoses” review, 2022.
• Cochrane Database of Systematic Reviews. “Topical antifungal agents for tinea nigra” (2022).
• World Health Organization (WHO). “Neglected tropical fungal infections” technical report, 2021.
• Cleveland Clinic. “How to treat fungal skin infections” patient guide, 2024.
• Journal of Clinical Microbiology. “Identification and antifungal susceptibility of Hortaea werneckii isolates” (2020).

```